Regulatory approval, regulatory review and marketing authorization

The company has extensive regulatory industry experience through taking key development projects to marketing authorisations in EU, Japan, US and many other jurisdictions.
Inger Mollerup is an expert within the area of biosimilar medicines, has contributed to development of biosimilar guidelines in EU, US, WHO and many other countries and is an experienced provider of training on biosimilars.